Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
Houssein H. Ayoub, Hiam Chemaitelly, Shaheen Seedat, et al.
Journal of Global Health (2021) Vol. 11
Open Access | Times Cited: 86

Showing 1-25 of 86 citing articles:

Effect of mRNA Vaccine Boosters against SARS-CoV-2 Omicron Infection in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 386, Iss. 19, pp. 1804-1816
Open Access | Times Cited: 362
Duration of mRNA vaccine protection against SARS-CoV-2 Omicron BA.1 and BA.2 subvariants in Qatar
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 214
SARS-CoV-2 antibody-positivity protects against reinfection for at least seven months with 95% efficacy
Laith J. Abu‐Raddad, Hiam Chemaitelly, Peter Coyle, et al.
EClinicalMedicine (2021) Vol. 35, pp. 100861-100861
Open Access | Times Cited: 173
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
Laith J. Abu‐Raddad, Hiam Chemaitelly, Joel A. Malek, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e1830-e1840
Open Access | Times Cited: 165
Association of Prior SARS-CoV-2 Infection With Risk of Breakthrough Infection Following mRNA Vaccination in Qatar
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
JAMA (2021) Vol. 326, Iss. 19, pp. 1930-1930
Open Access | Times Cited: 161
Characterizing the Qatar advanced-phase SARS-CoV-2 epidemic
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 143
Duration of immune protection of SARS-CoV-2 natural infection against reinfection
Hiam Chemaitelly, Nico Nagelkerke, Houssein H. Ayoub, et al.
Journal of Travel Medicine (2022) Vol. 29, Iss. 8
Open Access | Times Cited: 90
Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 70
Protection of Omicron sub-lineage infection against reinfection with another Omicron sub-lineage
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 67
Differential protection against SARS-CoV-2 reinfection pre- and post-Omicron
Hiam Chemaitelly, Houssein H. Ayoub, Peter Coyle, et al.
Nature (2025)
Open Access | Times Cited: 2
SARS-CoV-2 seroprevalence in the urban population of Qatar: An analysis of antibody testing on a sample of 112,941 individuals
Peter Coyle, Hiam Chemaitelly, Mohamed Ali Ben Hadj Kacem, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102646-102646
Open Access | Times Cited: 89
Herd Immunity against Severe Acute Respiratory Syndrome Coronavirus 2 Infection in 10 Communities, Qatar
Andrew Jeremijenko, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Emerging infectious diseases (2021) Vol. 27, Iss. 5, pp. 1343-1352
Open Access | Times Cited: 88
SARS-CoV-2 Infection Is at Herd Immunity in the Majority Segment of the Population of Qatar
Mohamed H. Al‐Thani, Elmoubasher Farag, Roberto Bertollini, et al.
Open Forum Infectious Diseases (2021) Vol. 8, Iss. 8
Open Access | Times Cited: 76
BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the Delta (B.1.617.2) variant in Qatar
Patrick Tang, Mohammad R. Hasan, Hiam Chemaitelly, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 71
One Year of SARS-CoV-2: Genomic Characterization of COVID-19 Outbreak in Qatar
Fatiha M. Benslimane, Hebah A. Al-Khatib, Ola Al-Jamal, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 65
Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study
Laith J. Abu‐Raddad, Hiam Chemaitelly, Houssein H. Ayoub, et al.
PLoS Medicine (2021) Vol. 18, Iss. 12, pp. e1003879-e1003879
Open Access | Times Cited: 64
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
Shaheen Seedat, Hiam Chemaitelly, Houssein H. Ayoub, et al.
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 63
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study
Hiam Chemaitelly, Houssein H. Ayoub, Sawsan AlMukdad, et al.
The Lancet Microbe (2022) Vol. 3, Iss. 12, pp. e944-e955
Open Access | Times Cited: 59
Covid-19 Vaccine Protection among Children and Adolescents in Qatar
Hiam Chemaitelly, Sawsan AlMukdad, Houssein H. Ayoub, et al.
New England Journal of Medicine (2022) Vol. 387, Iss. 20, pp. 1865-1876
Open Access | Times Cited: 55
Effect of prior infection, vaccination, and hybrid immunity against symptomatic BA.1 and BA.2 Omicron infections and severe COVID-19 in Qatar
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 40
Biological Properties of SARS-CoV-2 Variants: Epidemiological Impact and Clinical Consequences
Reem Hoteit, Hadi M. Yassine
Vaccines (2022) Vol. 10, Iss. 6, pp. 919-919
Open Access | Times Cited: 38
Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
Heba N. Altarawneh, Hiam Chemaitelly, Houssein H. Ayoub, et al.
EBioMedicine (2023) Vol. 95, pp. 104734-104734
Open Access | Times Cited: 32
Effectiveness of social distancing measures and lockdowns for reducing transmission of COVID-19 in non-healthcare, community-based settings
Caitriona Murphy, Wey Wen Lim, Cathal Mills, et al.
Philosophical Transactions of the Royal Society A Mathematical Physical and Engineering Sciences (2023) Vol. 381, Iss. 2257
Open Access | Times Cited: 29
Estimating protection afforded by prior infection in preventing reinfection: applying the test-negative study design
Houssein H. Ayoub, Milan Tomy, Hiam Chemaitelly, et al.
American Journal of Epidemiology (2023) Vol. 193, Iss. 6, pp. 883-897
Open Access | Times Cited: 25
All-cause and COVID-19 mortality in Qatar during the COVID-19 pandemic
Asma Ali Al-Nuaimi, Hiam Chemaitelly, Sandy Semaan, et al.
BMJ Global Health (2023) Vol. 8, Iss. 5, pp. e012291-e012291
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top